About Protibea Therapeutics
Protibea Therapeutics is a private company based in Georgetown, Texas, incorporated in 2021 in Delaware. It has reported $970,000 raised in two offerings on Form D since May 2021. Its chief executive is William Chamberlin.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 30, 2025 | Aug 18, 2025 | $200,000of $11.7M target | 2 | $100K | Equity, Right to acquire another securityRule 506(b) | Form D ↗ |
| May 10, 2021 | May 28, 2021 | $770,000of $1.2M target | 8 | $96,250 | Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $970,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Protibea Therapeutics's Form D filed Aug 18, 2025.
JM
Jim Moriarty
Executive officer and director
YG
Yu Ge
Director
WC
William Chamberlin
CEO and director
HO
Harry Oken
Director